Identifying novel proteins underlying schizophrenia via integrating pQTLs of the plasma, CSF, and brain with GWAS summary data
Authors:
Open Access
- 8 December 2022
- journal article
- research article
- Published by Springer Nature in BMC Medicine
- Vol. 20 (1) , 1-10
Abstract
Background: Schizophrenia (SCZ) is a chronic and severe mental illness with no cure so far. Mendelian randomization (MR) is a genetic method widely used to explore etiologies of complex traits. In the current study, we aimed to identify novel proteins underlying SCZ with a systematic analytical approach. Methods: We integrated protein quantitative trait loci (pQTLs) of the brain, cerebrospinal fluid (CSF), and plasma with the latest and largest SCZ genome-wide association study (GWAS) via a systematic analytical framework, including two-sample MR analysis, Steiger filtering analysis, and Bayesian colocalization analysis. Results: The genetically determined protein level of C4A/C4B (OR = 0.70, p = 1.66E−07) in the brain and ACP5 (OR = 0.42, p = 3.73E−05), CNTN2 (OR = 0.62, p = 2.57E−04), and PLA2G7 (OR = 0.71, p = 1.48E−04) in the CSF was associated with a lower risk of SCZ, while the genetically determined protein level of TIE1 (OR = 3.46, p = 4.76E−05), BCL6 (OR = 3.63, p = 1.59E−07), and MICB (OR = 4.49, p = 2.31E−11) in the CSF were associated with an increased risk for SCZ. Pathway enrichment analysis indicated that genetically determined proteins suggestively associated with SCZ were enriched in the biological process of the immune response. Conclusion: In conclusion, we identified one protein in the brain and six proteins in the CSF that showed supporting evidence of being potentially associated with SCZ, which could provide insights into future mechanistic studies to find new treatments for the disease. Our results also supported the important role of neuroinflammation in the pathogenesis of SCZ.Keywords
Funding Information
- The National Natural Science Foundation of China (81971188)
- Key Research and Development Program of Sichuan Province (2022NSFSC0749)
- the national key Research and Development Program of China (2022YFC2703101)
This publication has 37 references indexed in Scilit:
- PhenoScanner: a database of human genotype–phenotype associationsBioinformatics, 2016
- Schizophrenia risk from complex variation of complement component 4Nature, 2016
- The support of human genetic evidence for approved drug indicationsNature Genetics, 2015
- Inflammation and immunity in schizophrenia: implications for pathophysiology and treatmentThe Lancet Psychiatry, 2015
- Biological insights from 108 schizophrenia-associated genetic lociNature, 2014
- Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary StatisticsPLOS Genetics, 2014
- Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variantsInternational Journal of Epidemiology, 2010
- Polymorphisms in MICB are associated with human herpes virus seropositivity and schizophrenia riskSchizophrenia Research, 2007
- Schizophrenia as a Complex TraitArchives of General Psychiatry, 2003
- Systematic Screening of the LDL-PLA2Gene for Polymorphic Variants and Case-Control Analysis in SchizophreniaBiochemical and Biophysical Research Communications, 1997